Multi-institutional Study of Voice Disorders and Voice Therapy Referral: Report from the CHEER Network.

Published

Journal Article

OBJECTIVES: To assess perspectives of patients with voice problems and identify factors associated with the likelihood of referral to voice therapy via the CHEER (Creating Healthcare Excellence through Education and Research) practice-based research network infrastructure. STUDY DESIGN: Prospectively enrolled cross-sectional study of CHEER patients seen for a voice problem (dysphonia). SETTING: The CHEER network of community and academic sites. METHODS: Patient-reported demographic information, nature and severity of voice problems, clinical diagnoses, and proposed treatment plans were collected. The relationship between patient factors and voice therapy referral was investigated. RESULTS: Patients (N = 249) were identified over 12 months from 10 sites comprising 30 otolaryngology physicians. The majority were women (68%) and white (82%). Most patients reported a recurrent voice problem (72%) and symptom duration >4 weeks (89%). The most commonly reported voice-related diagnoses were vocal strain, reflux, and benign vocal fold lesions. Sixty-seven percent of enrolled patients reported receiving a recommendation for voice therapy. After adjusting for sociodemographic and other factors, diagnoses including vocal strain/excessive tension and vocal fold paralysis and academic practice type were associated with increased likelihood of reporting a referral for voice therapy. CONCLUSIONS: The CHEER network successfully enrolled a representative sample of patients with dysphonia. Common diagnoses were vocal strain, reflux, and benign vocal fold lesions; commonly reported treatment recommendations included speech/voice therapy and antireflux medication. Recommendation for speech/voice therapy was associated with academic practice type.

Full Text

Duke Authors

Cited Authors

  • Misono, S; Marmor, S; Roy, N; Mau, T; Cohen, SM

Published Date

  • July 2016

Published In

Volume / Issue

  • 155 / 1

Start / End Page

  • 33 - 41

PubMed ID

  • 27371624

Pubmed Central ID

  • 27371624

Electronic International Standard Serial Number (EISSN)

  • 1097-6817

Digital Object Identifier (DOI)

  • 10.1177/0194599816639244

Language

  • eng

Conference Location

  • England